Search Results

Filter
  • 1-10 of  4,979 results for ""Isoniazid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series.

  • Authors : B K; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Udupi, Karnataka, India.; Appaji R

Subjects: Isoniazid*/Isoniazid*/Isoniazid*/adverse effects ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/pharmacokinetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Nov; Vol. 80 (11), pp. 1725-1740. Date of Electronic Publication: 2024 Aug 13.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A DFT study on non-enzymatic degradations of anti-tuberculosis drug isoniazid.

  • Authors : Pornin W; Department of Chemistry, Faculty of Engineering, Rajamangala University of Technology Isan, KhonKaen Campus, KhonKaen, 40000, Thailand.; Phatchana R

Subjects: Isoniazid* ; Antitubercular Agents*; Density Functional Theory

  • Source: Journal of molecular modeling [J Mol Model] 2023 Aug 24; Vol. 29 (9), pp. 291. Date of Electronic Publication: 2023 Aug 24.Publisher: Springer Country of Publication: Germany NLM ID: 9806569 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

A child-friendly anti-infective gummy formulation: Design, physicochemical, micromechanical, and taste sensory evaluation.

  • Authors : Kean EA; College of Pharmacy, Faculty of Health, Dalhousie University, B3H 4R2, Halifax, NS, Canada.; Adeleke OA

Subjects: Isoniazid* ; Taste*; Humans

  • Source: Drug delivery and translational research [Drug Deliv Transl Res] 2024 May; Vol. 14 (5), pp. 1319-1337. Date of Electronic Publication: 2023 Nov 06.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.

  • Authors : Cao X; NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, 100730, Beijing, People's Republic of China.; Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, 100730, Beijing, People's Republic of China.

Subjects: Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/drug therapy ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/epidemiology ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/diagnosis

  • Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 May; Vol. 43Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A Mathematical Model for the Impact of 3HP and Social Programme Implementation on the Incidence and Mortality of Tuberculosis: Study in Brazil.

  • Authors : Delgado Moya EM; Institute of Collective Health (ISC), Federal University of Bahia (UFBA), Rua Basilio da Gama, Salvador, Bahia, 40.110-040, Brazil. .; Ordoñez JA

Subjects: Markov Chains* ; Isoniazid*/Isoniazid*/Isoniazid*/administration & dosage ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/administration & dosage

  • Source: Bulletin of mathematical biology [Bull Math Biol] 2024 Apr 25; Vol. 86 (6), pp. 61. Date of Electronic Publication: 2024 Apr 25.Publisher: Springer Country of Publication: United States NLM ID: 0401404 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Calcium Ion-Sodium Alginate-Piperine-Based Microspheres: Evidence of Enhanced Encapsulation Efficiency, Bio-Adhesion, Controlled Delivery, and Oral Bioavailability of Isoniazid.

  • Authors : Telange DR; Rajarshi Shahu College of Pharmacy, Maharashtra, Buldhana, India.; Datta Meghe College of Pharmacy, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India.

Subjects: Calcium* ; Isoniazid*; Alginates/Alginates/Alginates/chemistry

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2022 Mar 25; Vol. 23 (4), pp. 99. Date of Electronic Publication: 2022 Mar 25.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid.

  • Authors : Luciani-Giacobbe LC; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, 5000, Cordoba, Argentina.; Lorenzutti AM

Subjects: Isoniazid* ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy; Animals

  • Source: Drug delivery and translational research [Drug Deliv Transl Res] 2021 Jun; Vol. 11 (3), pp. 894-908. Date of Electronic Publication: 2020 Sep 08.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.

  • Authors : Pinhata JMW; Núcleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz (IAL), Av. Dr. Arnaldo, 351, 9º andar, São Paulo, SP, 01246-000, Brazil. .; Brandao AP

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacology ; Isoniazid/Isoniazid/Isoniazid/*pharmacology ; Mycobacterium tuberculosis/Mycobacterium tuberculosis/Mycobacterium tuberculosis/*drug effects

  • Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2021 Dec; Vol. 40Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis.

  • Authors : Huerta-García AP; Faculty of Chemical Sciences, Universidad Autónoma de San Luis Potosí, Av. Manuel Nava #6, Zona Universitaria, C.P. 78210, San Luis Potosí, S.L.P., Mexico.; Medellín-Garibay SE

Subjects: Models, Biological*; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*administration & dosage ; Isoniazid/Isoniazid/Isoniazid/*administration & dosage

  • Source: International journal of clinical pharmacy [Int J Clin Pharm] 2020 Aug; Vol. 42 (4), pp. 1217-1226. Date of Electronic Publication: 2020 Jul 07.Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Isoniazid/Isoniazid/Isoniazid/*therapeutic use ; Pyrazinamide/Pyrazinamide/Pyrazinamide/*therapeutic use

  • Source: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2019 Nov; Vol. 38Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  4,979 results for ""Isoniazid""